Robert L. Ferris
Impact in
- Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 228
- Cancer Immunotherapy and Biomarkers 130
- CAR-T cell therapy research 41
- Cancer Diagnosis and Treatment 33
- Lung Cancer Research Studies 26
-
- Head and Neck Cancer Studies 217
- Co-authors
- Athanassios Argiris (39 shared papers)Michalis V. Karamouzis (4 shared papers)William E. Gooding (71 shared papers)David Raben (3 shared papers)Soldano Ferrone (23 shared papers)Jonas T. Johnson (86 shared papers)Umamaheswar Duvvuri (89 shared papers)Theresa L. Whiteside (26 shared papers)
- Journals
- Journal of Clinical Oncology (72 papers)Head & Neck (41 papers)Oral Oncology (38 papers)Clinical Cancer Research (29 papers)Journal for ImmunoTherapy of Cancer (26 papers)
- Partner nations
- United StatesGermanyJapan
In The Last Decade
Robert L. Ferris
548 papers receiving 28.9k citations
Robert L. Ferris's Hit Papers
Peers
Comparison fields: 5 of 161
- Otorhinolaryngology 7.1k
- Oncology 10.6k
- Immunology 6.8k
- Cancer Research 2.8k
- Endocrinology, Diabetes and Metabolism 2.7k
Countries citing papers authored by Robert L. Ferris
This map shows the geographic impact of Robert L. Ferris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Ferris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Ferris more than expected).
Fields of papers citing papers by Robert L. Ferris
This network shows the impact of papers produced by Robert L. Ferris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Ferris. The network helps show where Robert L. Ferris may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert L. Ferris, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 557 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Head and neck cancer Hit paper breakdown → | 2008 | 1857 |
| 2 | Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples Hit paper breakdown → | 2011 | 586 |
| 3 | The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction Hit paper breakdown → | 2016 | 580 |
| 4 | Lipid accumulation and dendritic cell dysfunction in cancer Hit paper breakdown → | 2010 | 575 |
| 5 | The changing therapeutic landscape of head and neck cancer Hit paper breakdown → | 2019 | 558 |
| 6 | Immunology and Immunotherapy of Head and Neck Cancer Hit paper breakdown → | 2015 | 519 |
| 7 | The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC) Hit paper breakdown → | 2019 | 510 |
| 8 | Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer Hit paper breakdown → | 2020 | 472 |
| 9 | Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity Hit paper breakdown → | 2017 | 451 |
| 10 | Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next‐generation sequencing assay Hit paper breakdown → | 2014 | 375 |
| 11 | 2009 | 328 | |
| 12 | E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group Hit paper breakdown → | 2017 | 325 |
| 13 | 2015 | 293 | |
| 14 | 2010 | 274 | |
| 15 | Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules Hit paper breakdown → | 2018 | 273 |
| 16 | 2015 | 254 | |
| 17 | 2010 | 250 | |
| 18 | 2013 | 249 | |
| 19 | B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma Hit paper breakdown → | 2021 | 243 |
| 20 | 2016 | 232 |
About Robert L. Ferris
Robert L. Ferris is a scholar working on Oncology, Otorhinolaryngology, Immunology, Surgery and Pulmonary and Respiratory Medicine, having authored 557 papers that have together received 29.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (217 papers), Cancer Immunotherapy and Biomarkers (130 papers), Immunotherapy and Immune Responses (75 papers), Immune Cell Function and Interaction (44 papers), Lung Cancer Treatments and Mutations (41 papers), CAR-T cell therapy research (41 papers), Cancer Diagnosis and Treatment (33 papers) and Lung Cancer Research Studies (26 papers). The work is most often cited by research in Otorhinolaryngology (7.1k citations), Oncology (10.6k citations), Immunology (6.8k citations), Cancer Research (2.8k citations) and Endocrinology, Diabetes and Metabolism (2.7k citations). Robert L. Ferris has collaborated with scholars based in United States, Germany and Japan. Frequent co-authors include Athanassios Argiris, Michalis V. Karamouzis, William E. Gooding, David Raben, Soldano Ferrone, Jonas T. Johnson, Umamaheswar Duvvuri, Theresa L. Whiteside, Raja R. Seethala and Barbara Burtness. Their work appears in journals such as Journal of Clinical Oncology, Head & Neck, Oral Oncology, Clinical Cancer Research and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.